<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 06/20/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 06/20/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">THOMAS GRANINO</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">July 15, 1957 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>2825 NW 99 TERR<br/>SUNRISE, FL 33322, US<br/><br/>Work Phone:  954-937-6388<br/>Primary Home Phone:  954-607-0526<br/>Mobile Phone:  954-607-0526<br/>Email:  DWAY401@HOTMAIL.COM<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">403033446 2.16.840.1.113883.4.391.19615<br/>8X403033446 2.16.840.1.113883.4.391.19615.1<br/>9403473584 2.16.840.1.113883.4.572<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">3c8c64d5-5082-47dc-b1c2-9548dda5b2b5 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">October 22, 2024, 12:58:00 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">VALENTINA GHERGHINA</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">ASIF JAWAID</td></tr><tr><td class="td_header_role_value internal_format">2964 N STATE RD<br/>STE 110<br/>MARGATE, FL 330635715, US<br/><br/>Tel:  954-975-3102<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">448365422 2.16.840.1.113883.4.391.19615</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From June 20, 2024, 10:45:00   to June 20, 2024, 11:00:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.19615</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">ASIF JAWAID</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">2964 N STATE RD<br/>STE 110<br/>MARGATE, FL 330635715, US<br/><br/>Tel:  954-975-3102<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">DESIANO BARBARA<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  954-937-6388<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">THOMAS GRANINO<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  954-607-0526<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">ASIF JAWAID signed at June 20, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">2964 N STATE RD<br/>STE 110<br/>MARGATE, FL 330635715, US<br/><br/>Tel:  954-975-3102<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">HCA Physician Services Billing Info</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">2000 Health Park Drive<br/>Brentwood, TN 37027, US<br/><br/>Tel:  615-344-4777<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>4 month f/u</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Ozempic (0.25 or 0.5 MG/DOSE) 2 MG/1.5ML</td><td ID="instruction1">as directed Subcutaneous</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication2">Atorvastatin Calcium 40 MG</td><td ID="instruction2">1 tab at bedtime Orally Once a day</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication3">Toujeo Max SoloStar 300 UNIT/ML</td><td ID="instruction3">as directed Subcutaneous</td><td ID="medication3notes">62 units</td><td/><td/><td>Active</td></tr><tr><td ID="medication4">Rosuvastatin Calcium 20 MG</td><td ID="instruction4">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Ozempic (1 MG/DOSE) 4 MG/3ML</td><td ID="instruction5">as directed Subcutaneous</td><td ID="medication5notes">once weekly</td><td/><td/><td>Active</td></tr><tr><td ID="medication6">GlipiZIDE 10 MG</td><td ID="instruction6">1 tablet 30 minutes before breakfast Orally twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Farxiga 10 MG</td><td ID="instruction7">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Brilinta 90 MG</td><td ID="instruction8">1 tablet Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Metoprolol Succinate ER 25 MG</td><td ID="instruction9">TAKE 1 TABLET BY MOUTH EVERY DAY for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Lisinopril 10 MG</td><td ID="instruction10">TAKE 1 TABLET BY MOUTH EVERY DAY for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Tamsulosin HCl 0.4 MG</td><td ID="instruction11">1 capsule Orally Once a day</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication12">Synjardy 5-1000 MG</td><td ID="instruction12">1 tablet with meals Orally Twice a day</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication13">Spironolactone 25 MG</td><td ID="instruction13">1/2 tablet Orally Once a day for 90 days</td><td/><td>07/20/2023</td><td/><td>Not-Taking</td></tr><tr><td ID="medication14">Aspirin Low Dose 81 MG</td><td ID="instruction14">TAKE 1 TABLET BY MOUTH EVERY DAY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication15">Percocet 5-325 MG</td><td ID="instruction15">1 tablet as needed Orally every 6 hrs</td><td ID="medication15notes">every 6 hours PRN</td><td/><td/><td>Not-Taking</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Status:</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Patient is</td><td>a never smoker</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>70 in</td><td>06/20/2024</td></tr><tr><th ID="vital2">Weight</th><td>231 lbs</td><td>06/20/2024</td></tr><tr><th ID="vital3">BMI</th><td>33.14 kg/m2</td><td>06/20/2024</td></tr><tr><th ID="vital4">Blood pressure systolic</th><td>110 mm Hg</td><td>06/20/2024</td></tr><tr><th ID="vital5">Blood pressure diastolic</th><td>64 mm Hg</td><td>06/20/2024</td></tr><tr><th ID="vital6">Heart Rate</th><td>60 /min</td><td>06/20/2024</td></tr><tr><th ID="vital7">Oximetry</th><td>99 </td><td>06/20/2024</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>343911NHM NW HEART HEALTH INST MAR2</td><td>2964 N STATE RD STE 110 MARGATE, FL 330635715</td><td>06/20/2024</td><td>ASIF JAWAID</td><td>ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02 ; Coronary atherosclerosis due to severely calcified coronary lesion I25.84 ; CAD in native artery I25.10 ; Ischemic cardiomyopathy I25.5 ; Essential (primary) hypertension I10 ; Other hyperlipidemia E78.49 ; Type 2 diabetes mellitus without complications E11.9 ; Long term (current) use of insulin Z79.4 ; Low testosterone R79.89 ; Nephrolithiasis N20.0 ; Claudication I73.9 and BMI 33.0-33.9,adult Z68.33</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">06/20/2024</td><td>ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (ICD-10 - I21.02)</td><td/><td/><td/></tr><tr><td ID="ref2">06/20/2024</td><td>Coronary atherosclerosis due to severely calcified coronary lesion (ICD-10 - I25.84)</td><td/><td>A Healthy Heart: Care Instructions material was published</td><td/></tr><tr><td ID="ref3">06/20/2024</td><td>CAD in native artery (ICD-10 - I25.10)</td><td/><td/><td/></tr><tr><td ID="ref4">06/20/2024</td><td>Ischemic cardiomyopathy (ICD-10 - I25.5)</td><td/><td/><td/></tr><tr><td ID="ref5">06/20/2024</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref6">06/20/2024</td><td>Other hyperlipidemia (ICD-10 - E78.49)</td><td/><td/><td/></tr><tr><td ID="ref7">06/20/2024</td><td>Type 2 diabetes mellitus without complications (ICD-10 - E11.9)</td><td/><td/><td/></tr><tr><td ID="ref8">06/20/2024</td><td>Long term (current) use of insulin (ICD-10 - Z79.4)</td><td/><td/><td/></tr><tr><td ID="ref9">06/20/2024</td><td>Low testosterone (ICD-10 - R79.89)</td><td/><td/><td/></tr><tr><td ID="ref10">06/20/2024</td><td>Nephrolithiasis (ICD-10 - N20.0)</td><td/><td/><td/></tr><tr><td ID="ref11">06/20/2024</td><td>Claudication (ICD-10 - I73.9)</td><td/><td/><td/></tr><tr><td ID="ref12">06/20/2024</td><td>BMI 33.0-33.9,adult (ICD-10 - Z68.33)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Coronary atherosclerosis due to severely calcified coronary lesion</td><td>A Healthy Heart: Care Instructions material was published</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 6 Months, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:ASIF JAWAID, 12/11/2024 10:15:00 AM, 2964 N STATE RD, STE 110, MARGATE, FL, 330635715, 954-975-3102</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>GRANINO, THOMAS <span class="bold">DOB:</span> 07/15/1957 (66 yo M) <span class="bold">Acc No.</span> 8X403033446 <span class="bold">DOS:</span> 06/20/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">PROGRESS NOTE</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>GRANINO, THOMAS<br/><span class="bold">Account Number: </span>8X403033446</td><td align="right"><span class="bold">Provider: </span>ASIF JAWAID, DO</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>07/15/1957<span class="bold">   Age: </span>66 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>06/20/2024</td></tr><tr><td><span class="bold">Phone: </span>954-607-0526</td><td align="right"><span class="bold"> CHN#: </span>1922483841</td></tr><tr><td colspan="2"><span class="bold">Address: </span>2825 NW 99 TERR, SUNRISE, FL-33322</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>VALENTINA GHERGHINA</td></tr>--&gt;    </tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   4 month f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Patient History</span>: <br/>       66 y/o male with PMH of Htn, HLD, DM2, CAD s/p emergent PCI of LAD 12/30/22 in setting of acute anterior wall MI, using testosterone for low levels, HFrEF 45-50% (see echo Dec 2023), ureteral stone who presents for 4 mo f/u. He had initially presented to Woodmont Hospital for chest pain. He was noting to have anterior wall STEMI and transferred to NWMC and subsequently underwent radial PCI to the mLAD and POBA of the ostial D1.<br/><br/>CCS Class I angina.<br/>NYHA class I HF symptoms.<br/>Rutherford II claudication.<br/>Uses stationary bike 30 mins without stopping. He feels the stiffness in his legs and lower back when he gets up from a prolonged sitting position. Could be spinal stenosis rather than vascular claudication. Arterial dupplex of LE in Dec 2023 showed moderate disease. <br/><br/>His brother in law and sister in law, Thomas and Barbara Desiano are also my patients.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   All ROS reviewed and negative except for HPI.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span>  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> kidney stones x12 </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> HCA Northwest for Heart attack 12/30-01/0123</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Mother: deceased. Father: deceased. <br/><span class="content_span">both parents had hx of heart disease, bypass surgeries</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> Alcohol Use Patient does not use alcohol. Tobacco Status Patient is a never smoker. Caffeine: coffee, up to 3 cups daily. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAspirin Low Dose 81 MG Tablet Delayed Release TAKE 1 TABLET BY MOUTH EVERY DAY   Brilinta 90 MG Tablet 1 tablet Orally Twice a day Farxiga 10 MG Tablet 1 tablet Orally Once a day GlipiZIDE 10 MG Tablet 1 tablet 30 minutes before breakfast Orally twice a day Lisinopril 10 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY   Metoprolol Succinate ER 25 MG Tablet Extended Release 24 Hour TAKE 1 TABLET BY MOUTH EVERY DAY   Ozempic (1 MG/DOSE) 4 MG/3ML Solution Pen-injector as directed Subcutaneous  , Notes to Pharmacist: once weeklyRosuvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day Toujeo Max SoloStar 300 UNIT/ML Solution Pen-injector as directed Subcutaneous  , Notes to Pharmacist: 62 unitsTaking Aspirin Low Dose 81 MG Tablet Delayed Release TAKE 1 TABLET BY MOUTH EVERY DAY   Taking Brilinta 90 MG Tablet 1 tablet Orally Twice a day Taking Farxiga 10 MG Tablet 1 tablet Orally Once a day Taking GlipiZIDE 10 MG Tablet 1 tablet 30 minutes before breakfast Orally twice a day Taking Lisinopril 10 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY   Taking Metoprolol Succinate ER 25 MG Tablet Extended Release 24 Hour TAKE 1 TABLET BY MOUTH EVERY DAY   Taking Ozempic (1 MG/DOSE) 4 MG/3ML Solution Pen-injector as directed Subcutaneous  , Notes to Pharmacist: once weeklyTaking Rosuvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day Taking Toujeo Max SoloStar 300 UNIT/ML Solution Pen-injector as directed Subcutaneous  , Notes to Pharmacist: 62 unitsNot-TakingAtorvastatin Calcium 40 MG Tablet 1 tab at bedtime Orally Once a day Ozempic (0.25 or 0.5 MG/DOSE) 2 MG/1.5ML Solution Pen-injector as directed Subcutaneous  Percocet 5-325 MG Tablet 1 tablet as needed Orally every 6 hrs , Notes to Pharmacist: every 6 hours PRNSpironolactone 25 MG Tablet 1/2 tablet Orally Once a day Synjardy 5-1000 MG Tablet 1 tablet with meals Orally Twice a day Tamsulosin HCl 0.4 MG Capsule 1 capsule Orally Once a day Medication List reviewed and reconciled with the patientNot-Taking Atorvastatin Calcium 40 MG Tablet 1 tab at bedtime Orally Once a day Not-Taking Ozempic (0.25 or 0.5 MG/DOSE) 2 MG/1.5ML Solution Pen-injector as directed Subcutaneous  Not-Taking Percocet 5-325 MG Tablet 1 tablet as needed Orally every 6 hrs , Notes to Pharmacist: every 6 hours PRNNot-Taking Spironolactone 25 MG Tablet 1/2 tablet Orally Once a day Not-Taking Synjardy 5-1000 MG Tablet 1 tablet with meals Orally Twice a day Not-Taking Tamsulosin HCl 0.4 MG Capsule 1 capsule Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 70 in, Ht-cm: 177.8 cm, Wt: 231 lbs, Wt-kg: 104.78 kg, BMI: <span class="bold">33.14</span>, Weight Change: 1 lbs, Body Surface Area: 2.27, BP: <span class="bold">110/64</span>, HR: <span class="bold">60</span>, Oxygen sat %: <span class="bold">99</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">CARDIOLOGY:</span><br/>      Constitutional:  no acute distress, has appropriate affect. <br/>      Head and Face:  normocephalic, atraumatic. <br/>      Eyes:  PERRL, extraocular muscles intact. <br/>      Ears, Nose, Mouth, Throat:  oral mucosa moist without lesions. <br/>      Neck:  no carotid bruits, JVD, lymphadenopathy or thyromegaly. <br/>      Respiratory:  clear to auscultation bilaterally. <br/>      Cardiovascular:  S1, S2, without murmurs, rubs, gallops, heaves or thrills. <br/>      Chest:  normal. <br/>      Gastrointestinal/Abdomen:  abdomen soft, nontender, non distended, no organomegaly, no ascites, mass or pulsatile mass. <br/>      Musculoskeletal:  gait steady. <br/>      Extremities:  no, clubbing, cyanosis, edema, 2+ bilateral dorsal pedal artery. <br/>      Skin:  clean, dry and intact, warm. <br/>      Neurologic/Psychiatric:  alert and oriented to person, to place, to time, appropriate mood and affect.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery - I21.02 (Primary) 2. Coronary atherosclerosis due to severely calcified coronary lesion - I25.84 3. CAD in native artery - I25.10 4. Ischemic cardiomyopathy - I25.5 5. Essential (primary) hypertension - I10 6. Other hyperlipidemia - E78.49 7. Type 2 diabetes mellitus without complications - E11.9 8. Long term (current) use of insulin - Z79.4 9. Low testosterone - R79.89 10. Nephrolithiasis - N20.0 11. Claudication - I73.9 12. BMI 33.0-33.9,adult - Z68.33 </td></tr><tr><td>Plan: 12 lead EKG demonstrates NSR with large anterior wall infarct, Q-waves V1 to V6.<br/>NYHA class I-II HF symptoms. No angina. Rutherford class II claudication.<br/>STEMI  Dec 2022 in setting of acute anterior wall MI, 100% occluded LAD that was severely calcified for which 1 DES placed with excellent results via radial approach.<br/>Echocardiogram Dec 2022 demonstrates LV dysfunction EF 30-35% with apical hypokinesis.<br/>Echo December 2023 demonstrates LVEF 45-50%, grade 1 diastolic dysfunction, hypokinesis of the mid anteroseptal wall, mildly dilated left atrium, no critical valve disease, RVSP normal.<br/>Arterial duplex of the bilateral lower extremities December 2023 demonstrates moderate peripheral vascular disease in the left leg.  There is biphasic flow with diminished velocities of the mid and distal SFA is.  For now clinical monitoring.  Ultimately we will plan for leg angiogram once he is more symptomatic.  Rutherford class 2.<br/>Completed DAPT with ASA/Brilinta. Can DC Brilinta. <br/>Continue Crestor 20 mg daily. Goal LDL&lt;70. I have advised him to discontinue use of testosterone. We need aggressive control of his DM 2.<br/>GDMT with ACEi, BB abd SGLT2i: Lisinopril 10mg qD, Toprol XL 25mg qD. Farxiga 10mg qD. Due to soft BP could not tolerated MRA Spironolactone 12.5 mg qD. <br/>Suspect spintal stenosis rather than vascular claudication. If no lower back issues found, I will have him complete CTA Abd/Pelv w/ run-off for better delineation of his inflow vessels.<br/>F/u 6 mo <br/>=====<br/>CATH 12-30-22<br/>IMPRESSION:<br/>1. Successful emergent radial percutaneous coronary intervention for an acute<br/>anterior wall myocardial infarction, 100% occluded mid left anterior descending<br/>vessel, for which a Resolute Onyx Frontier 3.0 x 22 mm drug-eluting stent was<br/>deployed. Stent was post dilated to a 3.20 vessel diameter using high-pressure<br/>balloon inflations.<br/>2. Percutaneous transluminal coronary angioplasty and balloon angioplasty of<br/>the ostial 1st diagonal branch for 80% to 90% stenosis with excellent<br/>angiographic results.<br/>3. Mildly elevated filling pressures. Left ventricular end-diastolic pressure<br/>of 25. Formal 2D echocardiogram will be obtained to assess left ventricular<br/>function.<br/>COMMENTS AND RECOMMENDATIONS: In light of above angiographic findings,<br/>patient's acute anterior wall MI was secondary to 100% occluded mid LAD that<br/>was extensively calcified, for which 1 drug-eluting stent was placed with<br/>excellent angiographic results. He will be on dual anti-platelet therapy with<br/>aspirin and Brilinta in addition to moderate to high intensity statin and<br/>aggressive risk factor modification. He will be recommended to discontinue<br/>further use of testosterone therapy. Aggressive risk factor modification as<br/>per ACC/AHA guidelines.<br/>Asif Jawaid, DO<br/>==============<br/>Echo shows EF 30-35%, apex is down as expected, anteroapical wall hypokinetic.<br/>===========<br/>ECHO Dec 2023<br/>1. Mild to moderate left ventricular hypertrophy. Diastolic Function Mitral Inflow shows<br/>reversal of E/A wave consistent with grade 1 diastolic dysfunction. Normal left<br/>ventricular size. Normal left ventricular systolic function. LV Ejection Fraction is<br/>45-50 %.<br/>2. Resting Segmental Wall Motion Analysis: There is hypokinesis of the mid anteroseptal<br/>wall. The remaining left ventricular segments demonstrate normal wall motion.<br/>3. Normal right ventricular size. Normal right ventricular systolic function. RV systolic<br/>pressure of 15 mmHg. RV Systolic Pressure is normal.<br/>4. Mildly dilated left atrium.<br/>5. No aortic valve stenosis. Trace aortic valve regurgitation.<br/>6. Trace mitral valve regurgitation. Minimal mitral annular calcification.<br/>7. Trace tricuspid valve regurgitation.<br/>8. No evidence of pulmonic regurgitation.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Coronary atherosclerosis due to severely calcified coronary lesion</span> <br/>Notes: A Healthy Heart: Care Instructions material was published  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  Universal PAF (Patient Assessment Form): Fall Risk Assessment Date Screening Completed: 06/20/2024, Increased Fall Risk factors: No fall risk factors, History Falls in Past Year: No falls in the past year, A positive response is considered at risk. Addressed: Patient education. <br/>  Quality Measures: Fall Risk Assessment: Date of Screening Completed: 06/20/2024, Increased Fall Risk Factors: No fall risk factors, History Falls in Past Year: No falls in the past year, A positive response is considered at risk. Addressed: Patient education. Pneumococcal Vaccination - Patients 66 or older: Patient's Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccination. Influenza Immunization                                                                                                                                                            Patient's Immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit. Colorectal Cancer Screening: Patient's Colorectal cancer screening results were not documented and reviewed, reason not otherwise specified. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 6 Months</td></tr></tbody></table></li></ul><ul><li/></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by ASIF JAWAID , DO, OS13153  on 06/20/2024 at 02:39 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> ASIF JAWAID, DO</td><td align="right"><span class="bold">Date: </span>06/20/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 10/22/2024 12:58 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="13">CARDIOLOGY</td><td>Constitutional:</td><td colspan="2">no acute distress, has appropriate affect</td></tr><tr><td>Head and Face:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Eyes:</td><td colspan="2">PERRL, extraocular muscles intact</td></tr><tr><td>Ears, Nose, Mouth, Throat:</td><td colspan="2">oral mucosa moist without lesions</td></tr><tr><td>Neck:</td><td colspan="2"> no carotid bruits, JVD, lymphadenopathy or thyromegaly</td></tr><tr><td>Respiratory:</td><td colspan="2">clear to auscultation bilaterally</td></tr><tr><td>Cardiovascular:</td><td colspan="2">S1, S2, without murmurs, rubs, gallops, heaves or thrills</td></tr><tr><td>Chest:</td><td colspan="2">normal</td></tr><tr><td>Gastrointestinal/Abdomen:</td><td colspan="2">abdomen soft, nontender, non distended, no organomegaly, no ascites, mass or pulsatile mass</td></tr><tr><td>Extremities:</td><td colspan="2">no, clubbing, cyanosis, edema, 2+ bilateral dorsal pedal artery</td></tr><tr><td>Musculoskeletal:</td><td colspan="2">gait steady</td></tr><tr><td>Skin:</td><td colspan="2">clean, dry and intact, warm</td></tr><tr><td>Neurologic/Psychiatric:</td><td colspan="2">alert and oriented to person, to place, to time, appropriate mood and affect</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>